周 青, FACMG 浙江大学生命科学研究院研究员、博士生导师 美国临床分子遗传学执业主任医师 (DABMGG) 美国医学遗传学与基因组学学院专家委员 (FACMG)
| |
教育背景 2000 - 2004 西北大学生命科学学院 学士 2004 - 2009 中国科学院北京基因组研究所 博士
工作背景 2009 - 2010 中国科学院北京基因组研究所 助理研究员 2010 - 2015 美国国立人类基因组研究所 博士后 2015 - 2017 美国国立人类基因组研究所 研究人员 2015 - 2017 美国国立人类基因组研究所 临床分子遗传诊断人员 2017至今 浙江大学生命科学研究院 研究员
学术荣誉 1. 2013 美国国立卫生研究院 FARE Award 2. 2015 美国国立卫生研究院 Orloff Science Award 3. 2017 美国国立卫生研究院 GREAT Award 4. 2019 The International Society for Systemic AutoInflammatory Diseases (ISSAID) Young Investigator Award 5. 2019 求是科技基金会求是杰出青年学者奖 6. 2019 浙江大学2019年度十大学术进展 7. 2021 中国细胞生物学学会青年女科学家职业发展奖 A 项奖
学术兼职 1. 国际自身炎症疾病学会(ISSAID)委员, 美国医学遗传学与基因组学学院委员(FACMG) 2. 中华医学会医学遗传学分会第十届青委会副主委, 国家卫生健康委遗传咨询能力建设专家委员会委员,中国遗传学会遗传咨询分会委员,美洲华人遗传学会终身会员 主持基金 1. 主持国家自然科学基金-青年基金 2. 主持国家自然科学基金-面上项目2项 3. 主持浙江省杰出青年项目 4. 主持国家重点研发计划重点专项项目课题三(课题组长) 5. 主持浙江省领军型创新团队(首席) 6. 国家自然科学基金-专项项目(骨干) 7. 主持国家自然科学基金-国家杰出青年科学基金 国际学术会议特邀报告 1. The Third International Conference on Deficiency of ADA2, DADA2 cohort in China, Online meeting, 2020 2. ISSAID 10th International Congress, The NIH Cohort Study of DADA2 Patients: Novel Insights into Pathophysiology and Treatment with the TNF Inhibitors, Mar, 2019, Genoa, Italy. 3. ACR/ARHP Annual Meeting, Biallelic Hypomorphic Mutations in a Linear Deubiquitinase Define Otulipenia, an Early-Onset Systemic Autoinflammatory Disease. Nov, 2016, Washington, DC, USA. 4. ASHG 2016 Annual Meeting, Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease. Oct, 2016, Vancouver, Canada. 5. 23rd PReS Congress, Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease. Sep, 2016, Genoa, Italy. 6. ACR/ARHP Annual Meeting, HA20: A Novel Autoinflammatory Disease Caused By Haploinsufficiency of A20, Encoded By TNFAIP3. Nov, 2015, San Francisco, USA. (全会报告) 7. ISSAID Congress, A dominantly-inherited Behcet-like disorder caused by haploinsufficiency of the TNFAIP3/A20 protein. Sep, 2015, Dresden, Germany. 8. The National Human Genome Research Institute symposium, Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2. Dec, 2013, Bethesda, USA. 9. ACR/ARHP Annual Meeting, Intermittent Fever, Immune Dysregulation, And Systemic Vasculopathy Due To Loss-Of-Function Mutations In Adenosine Deaminase2. Oct, 2013, San Diego, USA. 10. ASHG 2013 Annual Meeting, Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes. Oct, 2013, Boston, USA. 11. The National Institute of Arthritis and Musculoskeletal and Skin Diseases symposium, Exome sequencing identified CECR1 causing early onset stroke. June, 2013, Bethesda, USA. 12. 7th Congress of ISSAID, Exome sequencing in monogenic Behçet-like disease. May, 2013, Lausanne, Switzerland. 13. 7th Congress of ISSAID, Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes. May, 2013, Lausanne, Switzerland. | |